The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas.

Dogansen, Sema; Selcukbiricik, Özlem; Bilir, Betul; Yarman, Emine

doi:10.1016/j.ghir.2016.04.004

The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas.

Dogansen S. C., Selcukbiricik Ö., Bilir B. E., Yarman S.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, cilt.29, ss.45-49, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.ghir.2016.04.004
Dergi Adı: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.45-49
Anahtar Kelimeler: Autoimmune thyroid disease, Hashimoto's thyroiditis, Prolactinoma, Hyperprolactinemia, Somatotrophinoma, Acromegaly, CLINICAL-PRACTICE GUIDELINE, GROWTH-HORMONE, HASHIMOTOS-THYROIDITIS, CANCER-RISK, HYPERPROLACTINEMIA, SOCIETY, CELLS, GLAND, BROMOCRIPTINE, ACTIVATION
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: Many studies have shown that prolactin (PRL) plays an important role in autoimmune diseases. The aim of this study was to compare the current frequency of autoimmune thyroid disease (ATD) in prolactinomas with another type of functional pituitary adenoma (FPA), somatotrophinoma. Another aim of the study was to evaluate possible factors related to thyroid autoimmunity and, the process of ATD in FPAs.